Larissa Sandalic

Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations

Éric Bouffet, Jordan R. Hansford, Maria Luisa Garrè et al. · New England Journal of Medicine · 2023 · 266 citations

Medicine, Oncology, Pharmacotherapy +17

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Mary O’Brien, Mark A. Socinski, Alexander Y. Popovich et al. · Journal of Thoracic Oncology · 2008 · 123 citations · Full text

Medicine, Oncology, Pharmacology +10

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia

Mikkael A. Sekeres, J. E. Lancet, Brent L. Wood et al. · Haematologica · 2012 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600–Mutant Pediatric High-Grade Glioma

Darren Hargrave, Keita Terashima, Junichi Hara et al. · Journal of Clinical Oncology · 2023 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Amir T. Fathi, Robert Chen, Tanya Trippett et al. · Blood · 2014 · 29 citations

Medicine, Oncology, Chemotherapy +16